Blogs

Please join us in welcoming our new CEO, Steven Salyer! Steven is an accomplished and innovative healthcare executive with extensive experience...

Prostate cancer is one of the most common types among men, but not all prostate cancers are alike. Some are slow-growing...

ARA radiologists are fully invested in the patients and medical providers of Central Texas, bringing expertise, service, and caring to work...

It’s Breast Cancer Awareness Month, and many are working to bring attention to breast cancer and the importance of screening with...

Recently designated a Radiopharmaceutical Therapy Center of Excellence, the ARA Theranostics Center brings expertise in molecular radiology to patients throughout Central...

In addition to their work in ARA Diagnostic Imaging centers and local hospitals, many ARA radiologists have thriving academic lives. For...

Thursday, July 14, was a notable day at ARA. The team at the ARA Theranostics Center administered the first dose in...

A PARADIGM SHIFT IN IDENTIFYING PROSTATE CANCER ARA is excited to offer a revolutionary radiotracer for the identification of prostate cancer. PET/CT...

FDA APPROVES PYLARIFY AS THE FIRST AND ONLY COMMERCIALLY AVAILABLE PSMA PET IMAGING AGENT FOR PROSTATE CANCER On May 27, 2021,...

AMYVID FOR ALZHEIMER’S DIAGNOSIS In 2012, the FDA approved Amyvid (florbetapir F 18), a radiopharmaceutical for use in PET imaging of...